久久综合日本久久综合,亚洲成AV人片在线观看天堂无码,国产在线视频不卡一区二区,久久久久看免费高清特色大片

產(chǎn)品分類(lèi)

BioSim Dilpacimab ELISA Kit(KDJ65301)
  • 品牌:AntibodySystem
  • 產(chǎn)地:France
  • 型號:96 assays
  • 貨號:KDJ65301
  • 發(fā)布日期: 2022-07-25
  • 更新日期: 2024-07-23
產(chǎn)品詳請
產(chǎn)地 France
保存條件 2-8 ℃
品牌 AntibodySystem
貨號 KDJ65301
用途 For Research Use Only.
檢測方法 Elisa
保質(zhì)期 1 year
規格 96 assays
適應物種 Dilpacimab
檢測限 0.156 ug /ml
數量 99999
標記物 Unconjugate
純度 95%%
樣本 Plasma, Serum
應用 Elisa
是否進(jìn)口


Catalog No.

KDJ65301

Stability and Storage

The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition.

Detection method

Colorimetric

Precision

CV<20%

Sample type

Plasma, Serum

Assay type

Quantitative

Sensitivity

0.156 μg/ml

Range

0.31-5 μg/mL

Recovery

80-120%

Specifications

Dilpacimab

Alternative Names

ABT-165, PR-1283233, CAS: 1791420-09-1

Background

Dilpacimab (formerly ABT-165), a novel dual-variable domain immunoglobulin, targets both delta-like ligand 4 (DLL4) and VEGF pathways. Here, we present safety, pharmacokinetic (PK), pharmacodynamic (PD), and preliminary efficacy data from a phase I study (trial registration ID: NCT01946074) of dilpacimab in patients with advanced solid tumors. Eligible patients (≥18 years) received dilpacimab intravenously on days 1 and 15 in 28-day cycles at escalating dose levels (range, 1.25–7.5 mg/kg) until progressive disease or unacceptable toxicity.

Shipping

2-8 ℃

Note

For Research Use Only.


Aiming to develop the most reliable bioreagents, AntibodySystem SAS was founded in 2019 in France by a team of professionals from top industrial companies and research institutes. The collective scientific and technical experiences in our team have brought breaking throughs in multiple product developments, including recombinant antibodies, recombinant proteins, biosimilar, RUO ELISA kits and other related products. By working with talented researchers and technicians, AntibodySystem continues to upgrade product qualities and lower the overall cost, offering accountable and affordable solutions for biolabs all over the world. Since its establishment, AntibodySystem has built long term and stable collaborations with academia, pharmaceutical industry, biotech companies and research hospitals, supporting their R&D by AntibodySystem's bioreagents with excellent data accuracy and reproducibility.




AntibodySystem由具有30多年蛋白抗體開(kāi)發(fā)經(jīng)驗的 創(chuàng )立于法國,專(zhuān)注于生命科學(xué)和生物制藥領(lǐng)域研究,總部位于法國斯特拉斯堡市。AntibodySystem自主開(kāi)發(fā)了高效、高產(chǎn)的真核重組表達系統,利用該系統生產(chǎn)了高質(zhì)量的重組蛋白、抗體產(chǎn)品。目前產(chǎn)品包括藥物靶點(diǎn)蛋白以及對照抗體藥物、Invivo功能性抗體、SAA系列流式抗體、PEG抗體、磷酸化抗體、抗小分子抗體、ADA抗體、PK&ADA ELISA試劑盒。


普健生物作為AntibodySystem在亞洲區授權 ,致力于為廣大科研工作者提供 的產(chǎn)品服務(wù)。

如果您對我們的產(chǎn)品感興趣,請聯(lián)系027-65279366。

以上產(chǎn)品僅用于科研,產(chǎn)品信息以產(chǎn)品 為準






乐至县| 龙口市| 荥经县| 余干县| 海晏县| 湘西| 永修县| 华容县| 金川县| 五大连池市| 安多县| 石嘴山市| 年辖:市辖区| 南皮县| 合水县| 泸水县| 合川市| 达日县| 红安县| 堆龙德庆县| 锡林郭勒盟| 武汉市| 安西县| 仙桃市| 栾川县| 久治县| 永修县| 兴山县| 皋兰县| 保山市| 从江县| 十堰市| 铜梁县| 清河县| 赤峰市| 阿鲁科尔沁旗| 吉木萨尔县| 清水河县| 开原市| 札达县| 大丰市|